·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
µ¶ÀÚÁ¦º¸
Event
´º½º
Àüü±â»ç
Á¤Ã¥ · ¹ý·ü
Á¦¾à · ¹ÙÀÌ¿À
¾à±¹ · º´¿ø
Ä«µå´º½º
ÆÊTV
À̽´¿µ»ó
DPÃÊ´ë¼®
À̽´Áø´Ü
¾Ë¾Æº¸Àâ
¿ÀÇǴϾð
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
±âÀÚ¼öø
Ưº°±â°í
English
Policy
Opinion
Company
Product
Interview
TVÆÊµµ¶ó
ÆÊTube
ÆÊ¼îÇÎ
³ª´Â¾à»ç´Ù
ÆÊµå¶ó¸¶
ÆÊ¾ÆÄ«µ¥¹Ì
ÃʽÉŬ·¡½º
OTC»ó´ã
Á¦Ç°°ÁÂ
Çмú°ÁÂ
°æ¿µ°ÁÂ
Ä¿¹Â´ÏƼ
ÆÊ¸®Äí¸£Æ®
ä¿ëÁ¤º¸
PHARMARCY
ÀÎÀçÁ¤º¸
DPºÎµ¿»ê
¾à±¹ Q&A
¾à»ç´ëÃâ
¾à»ç½Å¿ë´ëÃâ
¼¼¹«»ó´ã
¼¼¹«·³ë¹«
¹ý·ü»ó´ã
¾à±¹°æ¿µ°úâ¾÷
ÀǾàÀÚ·á½Ç
ÀǾàÇàÁ¤
¾à»ç¾à±¹
ÀǷẴ¿ø
Á¦¾àÀ¯Åë
º¸µµÀÚ·á
ÆÊ½ºÅ¸Å¬·´
ÀÎ»ç · ºÎÀ½
¾à±¹ÀåÅÍ
ȸ»ç¼Ò°³
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
»ç¾÷Á¦ÈÞ
ÀÎÅͳݽŹ®À±¸®°·É
µ¶ÀÚÁ¦º¸
±âÀÚÀ±¸®°·É
ÀÚÀ²¼¾à¼
¿ø°ÝÁö¿ø¿äû
Event & ¼¼¹Ì³ª
Àüü±â»ç
±×·¡ÇÈ
Á¤Ã¥¡¤¹ý·ü
Á¦¾à¡¤¹ÙÀÌ¿À
¾à±¹¡¤º´¿ø
±âȹ¡¤Å½»ç
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
񃯇
񃯇
ÀǾàǰ
³¹¾Ë½Äº°
µ¥Àϸ®ÆÊ Live Search
´Ý±â
´º½º
>
InfoStockNews
¾È±¹¾àǰ, Áö¿¤ÆÊÅØ 'Áö¿¤À̺ÎÅåÅ©¸²' µ¶Á¡ À¯Å롤ÆÇ¸Å
2025-05-22 13:19:00
[µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] ¾È±¹¾àǰÀº Áö¿¤ÆÊÅØ°ú ¡®Áö¿¤À̺ÎÅåÅ©¸² 5%¡¯ÀÇ ±¹³» À¯Å롤ÆÇ¸Å°è¾àÀ» ü°áÇß´Ù°í 22ÀÏ ¹àÇû´Ù. ¾È±¹¾àǰÀº ¸ðµç º´¡¤ÀÇ¿ø¿¡¼ Áö¿¤À̺ÎÅå...
õ½ÂÇö ±âÀÚ
'½Ã¹Ð·¯ ºÐ»ç' »ï¹Ù "ÀÌÇØ»óÃæ ÇØ¼Ò...±â¾÷°¡Ä¡ ±Ø´ëÈ"
2025-05-22 12:05:42
[µ¥Àϸ®ÆÊ=Â÷ÁöÇö ±âÀÚ] ±âÁ¸¿¡´Â »ï¼º¹ÙÀÌ¿À·ÎÁ÷½º¿¡ ÅõÀÚÇÏ¸é ¾ÈÁ¤¼º À§ÁÖÀÇ À§Å¹°³¹ß»ý»ê(CDMO)¿Í °íÀ§Ç衤°í¼öÀÍ ¼º°ÝÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯¶ó´Â ÀÌÁúÀûÀÎ µÎ »ç¾÷ ºÎ...
Â÷ÁöÇö ±âÀÚ
»ï¼º¹ÙÀÌ¿À, ÀÎÀûºÐÇÒÇØ 'CDMO¡¤½Ã¹Ð·¯' »ç¾÷ ºÐ¸®
2025-05-22 08:33:59
[µ¥Àϸ®ÆÊ=Â÷ÁöÇö ±âÀÚ] »ï¼º¹ÙÀÌ¿À·ÎÁ÷½º(´ëÇ¥ÀÌ»ç Á¸¸²)´Â ´Ü¼ø¡¤ÀÎÀûºÐÇÒ ¹æ½ÄÀ¸·Î »ï¼º¿¡ÇǽºÈ¦µù½º¸¦ ¼³¸³ÇØ ¹ÙÀÌ¿ÀÀǾàǰ À§Å¹°³¹ß»ý»ê(CDMO)»ç¾÷°ú ¹ÙÀÌ¿À½Ã...
Â÷ÁöÇö ±âÀÚ
´ëÇüÁ¦¾à R&D ÅõÀÚ È®´ë...ÇÑ¹Ì 'ÃÖ´Ù'¡¤JWÁᨚ 54%¡è
2025-05-22 05:59:24
[µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] ´ëÇü Á¦¾à±â¾÷µéÀÌ ¿ÃÇØ µé¾î ¹Ì·¡ ¸Ô°Å¸® È®º¸¸¦ À§ÇØ ¿¬±¸°³¹ß(R&D) ÅõÀÚ¸¦ È®´ëÇß´Ù. ´ëÇü ÀüÅëÁ¦¾à»ç 5°÷ Áß 3°÷Àº Áö³Çغ¸´Ù R&D ÅõÀÚ ±Ô...
õ½ÂÇö ±âÀÚ
'IPO ´ë¹Ú' SK¹ÙÆÊ¡¤¹Ù»ç, ÁÖ°¡ Èñºñ °¡¸¥ ¼ºÀå¾à¼Ó ÀÌÇà·ü
2025-05-22 05:44:45
[µ¥Àϸ®ÆÊ=Â÷ÁöÇö ±âÀÚ] SK±×·ìÀÇ ´ëÇ¥ ¹ÙÀÌ¿À °è¿»ç SK¹ÙÀÌ¿ÀÆÊ°ú SK¹ÙÀÌ¿À»çÀ̾ð½ºÀÇ »óÀå ÀÌÈÄ ÁÖ°¡ È帧ÀÌ ±Ø¸íÇÏ°Ô ¾ù°¥·È´Ù. SK¹ÙÀÌ¿ÀÆÊ ÁÖ°¡´Â °ø¸ð°¡ ´ëºñ 88%...
Â÷ÁöÇö ±âÀÚ
HLB, ÀǾàǰ B2C À¯Åë ¹ýÀÎ ¼³¸³¡¦»ç¾÷´Ù°¢È ¼Óµµ
2025-05-21 11:59:44
[µ¥Àϸ®ÆÊ=Â÷ÁöÇö ±âÀÚ] HLB°¡ ÀǾàǰ ±â¾÷-¼ÒºñÀÚ °£ °Å·¡(B2C) »ç¾÷À» À§ÇÑ ½Å±Ô ¹ýÀÎÀ» ¼³¸³Çß´Ù. ½Å¾à°³¹ß »ç¾÷ÀÇ ¸®½ºÅ©¸¦ º¸¿ÏÇÏ°í ¾ÈÁ¤ÀûÀÎ ¼öÀÍ¿ø(ij½ÃÄ«¿ì)À» ...
Â÷ÁöÇö ±âÀÚ
Çѹ̾àǰ "¿Àº¸µ§½º, ÀÓ»ó 3»ó¼ ¿ì¼öÇÑ È¿°ú È®ÀÎ"
2025-05-21 10:26:48
[µ¥Àϸ®ÆÊ=Â÷ÁöÇö ±âÀÚ] Çѹ̾àǰ(´ëÇ¥ÀÌ»ç ¹ÚÀçÇö)ÀÌ »ï¼º¹ÙÀÌ¿À¿¡Çǽº¿Í °øµ¿ ÆÇ¸Å Çù¾àÀ» ¸ÎÀº °ñ´Ù°øÁõ Ä¡·áÁ¦ ÇÁ·Ñ¸®¾Æ(¼ººÐ¸í µ¥³ë¼ö¸¿) ¹ÙÀÌ¿À½Ã¹Ð·¯ ¿Àº¸µ§½º...
Â÷ÁöÇö ±âÀÚ
ÇѹÌ, ÇÑ´Þ»õ ÁÖ°¡ 40%¡è...°æ¿µ±Ç ºÐÀï ±¸¿øÅõ¼öµé '¹æ±ß'
2025-05-21 05:58:51
[µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] Çѹ̻çÀ̾ð½ºÀÇ ÁÖ°¡°¡ ÃÖ±Ù µé¾î °¼¼¸¦ º¸À̰í ÀÖ´Ù. Áö³ ÇÑ´Þ»õ ÁÖ°¡°¡ 40% »ó½ÂÇß´Ù. Áö³ÇØ Çѹ̻çÀ̾𽺠°æ¿µ±Ç ºÐÀï ´ç½Ã ¸ð³à Ãø ±¸¿ø...
õ½ÂÇö ±âÀÚ
'»õ³»±â CDMO' ·Ô¹Ù, ¸ÅÃâ 4Q ¿¬¼Ó Ç϶ô¡¦ÅõÀÚ´Â È®´ë
2025-05-20 12:00:26
[µ¥Àϸ®ÆÊ=Â÷ÁöÇö ±âÀÚ] ·Ôµ¥±×·ì ¹ÙÀÌ¿ÀÀǾàǰ À§Å¹°³¹ß»ý»ê(CDMO) °è¿»ç ·Ôµ¥¹ÙÀÌ¿À·ÎÁ÷½º 1ºÐ±â ½ÇÀûÀÌ ±Þ°¨Çß´Ù. Àü³â µ¿±â ´ëºñ ¸ÅÃâÀº 4ºÐÀÇ 1 ¼öÁØÀ¸·Î Âɱ׶ó...
Â÷ÁöÇö ±âÀÚ
»þÆä·Ð, ¼¼°è ÃÖÃÊ '¾ÆÅäÇÇ Ä¡·á ¼Ö·ç¼Ç' ±¹Á¦ ÇмúÁö °ÔÀç
2025-05-20 10:43:22
[µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] »þÆä·ÐÀº Â÷¼¼´ë ¾ÆÅäÇÇ ÇǺο° Ä¡·áÁ¦ ¡®´©°Ö(NuGel)¡¯ÀÇ ±¹³» ÀÓ»ó 2a»ó ¿¬±¸ °á°ú°¡ ¡®ÇÁ·ÐƼ¾î½º ÀÎ À̹³î·ÎÁö(Frontiers in Immunology, ...
À̼®ÁØ ±âÀÚ
<
11
12
13
14
15
16
17
18
19
20
>
ä¿ë
¼Óº¸
ÁÖ¹®½Ã °áÁ¦±Ý¾×ÀÇ 5% Áï½Ã ÇÒÀÎ!
[µð¶óÀÌÇÁ] 9ÀÎÄ¡ ¼Å§·¹ÀÌÅÍ
48%
23,501¿ø
[·Îº¸¶ô] Qrevo S ·Îº¿Ã»¼Ò±â
42%
870,000¿ø
[»ïÇö] ¼Òµ¶¿ë¿¡Åº¿Ã
5%
760¿ø
Å»¸ð¼¤Çª1À§¡Ú¸ðÅ彺¼¤Çª
44%
29,450¿ø
¹®¶óÀÌÆ® À¯»ê±Õ
47%
27,930¿ø
¾ß»ý ºôº£¸®&¶óÁ¸® 6ÆÑ
25%
32,300¿ø
¿»·Î¿ì¿¡ÀÌÀ¯ ÇÁ·ÎÆú¸®½º
32%
21,280¿ø
[½ÅÀÏ] ¹«¼± 4ÀÎÄ¡ Å×ÀÌºí ¼±Ç³±â
20%
22,500¿ø
[Ȩ¹ÙÀÌȨ] ³¯°³¾ø´Â ¼±Ç³±â
66%
89,900¿ø
¿Ãµ¥ÀÌ KF94 ¸¶½ºÅ©
8%
250¿ø
[µð¶óÀÌÇÁ] ºÐ¸®Çü ¼±Ç³±â+°¡¹æÁõÁ¤
68%
41,500¿ø
[¿À¶óƽ½º] ±¸°À¯»ê±Õ 5°³¿ùºÐ
62%
85,500¿ø
[¶ó¿¤] À¯±â³ó ¼ø¸é »ý¸®´ë
34%
5,605¿ø
[ij¸®¾î] Ŭ¶óÀ©µå 20L Á¦½À±â
46%
299,000¿ø
¾ÆÀÌ¿ø Ŭ¸®³Ê¼¼Á¤ 20¸ÅÀÔ
12%
88,825¿ø
[ÇÏÀÌÀ£] ÃÊÀ¯Ãò¾îºí 120Á¤
45%
36,100¿ø
[¿À¶óƽ½º] ÀÓÇöõƽ½º 5°³¿ùºÐ
61%
118,750¿ø
[Çϸ²] ¿ë°¡¸® ġŲ³Ê°Ù 1+1
38%
17,005¿ø
¹Ù¸£´Â ÆÄ½º Ä𸵠½ºÆ÷Ã÷°Ö
5%
9,500¿ø
[¸¶´õ½ºÆÊ] ±ÃÁß½ÖȰí 60Æ÷
64%
30,400¿ø
[Áß¾Ó·¦] Æ÷½ºÆ®¹ÙÀÌ¿Àƽ½º
47%
32,965¿ø
µ¥Àϸ®¸®¹öÇコ 90Á¤
22%
11,845¿ø
[·Îº¸¶ô] F25 RT ¾ÆÄí¾ÆÃ»¼Ò±â
30%
529,000¿ø
[ÆÄ¸¶ÇǾÆ] µÎ³ú¿£ Æ÷½ºÆÄƼµô 30Æ÷
25%
13,585¿ø
¾Ë¸² ¡¤ °øÇ¥
±³À° ¡¤ °ÁÂ
¾à±¹ Q&A
Á¢¼ö ¡¤ ¹®ÀÇ
¾Ë¸²
»õ·Î¿öÁø Ç®ÄÉ¾î ÆÐŰÁö&Áø¿´ë POSM ½ÅûÇϱ⠢º
¾Ë¸²
īī¿ÀÀÎÁõÀ¸·Î 1ºÐ¸¸¿¡ Á¾Çռҵ漼 °£Æí¿¹Ãø GO ¢º
¾Ë¸²
2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY
¾Ë¸²
ÈѽºÅ»¢ç ½´ÆÛÀÚÀÓÀÇ SUPER½ºÆåÆ®·³ & ½Å±Ô Áø¿´ë ¢º
¾Ë¸²
[µ¿¾ÆÁ¦¾à]´ç½ÅÀÇ ÇÏ·ç¿¡ ¾î¶² ¸¶±×³×½·ÀÌ ÇÊ¿äÇѰ¡¿ä?
¾Ë¸²
´Ù ´Ù¸¥ ÅëÁõ, ´Ù °°Àº ¼±ÅÃ! ŸÀÌ·¹³î EVENT ¢º
¾Ë¸²
All About ¾Ë·¹±×¶ó! ½ÉÆ÷Áö¾ö ÇöÀå ´Ù½Ãº¸±â GO
¾Ë¸²
°·ÂÇÑ 1À§ÀÇ ºñ°á! ·Î°ÔÀÎÆû ¸ðÙ¾¸àÅ͸® È®ÀÎÇϱ⠢º
D-190
ij³ª´Ù¾à»ç ½ÃÇè, ÀÌ·¸°Ô ¹Ù²ï´Ù! ( ~12.31 )
D-190
¾à¾÷°è ´ëÇ¥ ±³À°»çÀÌÆ®, ÆÊŬ·¡½º ( ~12.31 )
¼¼¹«¡¤³ë¹«
¿¬±Ý°èÁ ¼¼¾×°øÁ¦
¾à±¹´ëÃâ
¾à±¹¿î¿µÀÚ±Ý
¹ý·ü»ó´ã
¾à±¹ °³¼³ °¡´É ¿©ºÎ
¼¼¹«»ó´ã
´ç¼Ò¸ð¼ºÀç·á ó¹æÀÇ ¼¼¹«Ã³¸®°üÇØ ±Ã±ÝÇÑ °ÍÀÌ ÀÖ
¾à±¹°æ¿µ°ú â¾÷
Á¶¸¸°£ Æó¾÷ ¿¹Á¤Àä, Æó¾÷ÀÏÀº ¾à±¹À» ´ÝÀº ³¯
ÀÚ»ê°ü¸®
Á¾½Åº¸Çè °è¾àÀÚ¿Ü ¼öÀÍÀÚ º¯°æ °¡´ÉÇѰ¡¿ä?
±³À° °Á ¹× ¾Ë¸² ±¤°í ¾È³» ÆäÀÌÁö
¿¬¼ö, ±³À°, ¼¼¹Ì³ª, Çмú°Á ¹× ±â¾÷±³À°, ¸ðÁý
°øÇ¥, Åä·Ðȸ, ÀǾàǰ º¯°æ ¾È³» ¹× °¢Á¾ Çà»ç
¾Ë¸² ±¤°í¸¦ ÇØµå¸³´Ï´Ù.
(Á¢¼ö ¹®ÀÇ ¹Ù·Î°¡±â)
¿À´ÃÀÇ
ÇÖ´º½º
1
À§±â¿Í »õ ±âȸ...ÁÖÀÎ ¹Ù²î´Â ´ë¾î±Þ ¹ÙÀÌ¿Àº¥Ã³µé
2
±Ç¿µÈñ ȸÀå "â°íÇü¾à±¹, °ø°ø¡¤Àü¹®¼º ºÎÁ¤...ÀÏÅ» ÇàÀ§"
3
À¯ÇÑ ÀÚ»ê 1.5Á¶, ´ë¿õ Çö±Ý 3õ¾ï¡¦°øÀÍÀç´Ü Á¸Àç°¨ '¾¦'
4
¿õ»óÁß¾Óº´¿ø Æó¾÷ 21°³¿ù¸¸ Àç°³¿ø...Æó¾÷ ¾à±¹µé ±â»çȸ»ý
5
'Á©ÀÜÁî' °ð ƯÇã ¸¸·á...´ë¿õ, °í¿ë·® Æ÷ÇÔ Á¦³×¸¯ Çã°¡
6
NIP ³ë¸®´Â CSL½ÃÄû·¯½º¡¦»ïÁø°ú ¹é½Å »ç¾÷ ½Ã³ÊÁö ¿¹°í
7
»ï¹Ù, ÇÁ·Ñ¸®¾Æ ½ÃÀå ÇÕ·ù¡¦Á¾±Ù´ç¡¤´ë¿õ¡¤ÇÑ¹Ì ´ë¸®Àü
8
"AI½Å¾à ¼±Á¦ ´ëÀÀ"¡¦º¹ÁöºÎ, 2Â÷ Ãß°æ 54¾ï¿ø ½Å±Ô Æí¼º
9
[±âÀÚÀÇ ´«] ¾à±¹ ¾Õ ÀǾàǰ ¹è¼Û, ÀÌ´ë·Ð ¾ÈµÈ´Ù
10
°æÂû, ¾à±¹ ´ë»ó ³ë¼î»ç±â ¼ö»ç ¼Óµµ...»ç±â¹ü 3¸í ±¸¼Ó